title: Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
authors.forename: Grigorios
authors.initials: G
authors.lastname: Giamouzis
authors.forename: Georgios
authors.initials: G
authors.lastname: Giannakoulas
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Tsarpalis
authors.forename: Syed A
authors.initials: SA
authors.lastname: Agha
authors.forename: Vasiliki
authors.initials: V
authors.lastname: Georgiopoulou
authors.forename: Andreas
authors.initials: A
authors.lastname: Kalogeropoulos
authors.forename: Haralambos
authors.initials: H
authors.lastname: Karvounis
authors.forename: Javed
authors.initials: J
authors.lastname: Butler
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004280:Dobutamine / Q000008:administration & dosage / Q000627:therapeutic use; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D020097:Natriuretic Peptide, Brain / Q000097:blood; D011237:Predictive Value of Tests; D011379:Prognosis; D011724:Pyridazines / Q000008:administration & dosage / Q000627:therapeutic use*; D000077464:Simendan; D013997:Time Factors
chemical_list: D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D020097:Natriuretic Peptide, Brain; D000077464:Simendan; D004280:Dobutamine